Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial - Egberts, Friederike; Gutzmer, R.; Ugurel, S.; Becker, J. C.; Trefzer, U.; Degen, A.; Schenck, F.; Frey, L.; Wilhelm, T.; Hassel, Jessica C.; Schadendorf, D.; Livingstone, E.; et al. (Annals of oncology, 2011)
Version of Record 6 January 2020